CELLISTEM-OA

N/A

Report date: 2024/11/24 20:00:04

Base Information

Drug NameCELLISTEM-OA
Drug Alias NameCellistem-OA (biological therapy based on mesenchymal stem cells derived from Wharton's jelly of umbilical cord)
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsOsteoarthritis, Knee
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesFundación Oftalmológica de Santander Clínica Carlos Ardila Lulle
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesFundación Oftalmológica de Santander Clínica Carlos Ardila Lulle
Active IndicationsN/A
Inactive IndicationsOsteoarthritis, Knee

Other Information

ATC CodeN/A
Related LinksN/A